CCO Interactive Case Challenges

Interactive Case Challenges: Treatment of Head & Neck Cancer

Interactive Case Challenges

A Newly Diagnosed Patient With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma

CME Program Director:
Corey J. Langer, MD

Faculty:

Marshall Posner, MD headshot
  • Marshall Posner, MD

CME CREDIT INFORMATION

Release Date: 01/13/06

Expiration Date: 01/12/07


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Test your ability to diagnose and treat an otherwise healthy younger patient with locoregionally advanced oropharyngeal squamous cell carcinoma.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the proper methods for diagnosis of a younger patient without traditional risk factors for squamous cell carcinoma of the head and neck
  • Recount the impact of chemoradiotherapy in squamous cell carcinoma of the head and neck
  • Describe new directions in therapy including the use of targeted agents and strategies to reduce radiation-associated toxicity

A 64-Year-Old Male With a Smoking History, Newly Diagnosed With T3 Stage IVa Laryngeal Carcinoma

Program Director:
Corey J. Langer, MD

Faculty:

David I. Rosenthal, MD headshot
  • David I. Rosenthal, MD

CME CREDIT INFORMATION

Release Date: 01/13/06

Expiration Date: 01/12/07


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Test your ability to diagnose and treat a 64-year-old male with newly diagnosed stage IVa laryngeal carcinoma.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe appropriate initial management of a patient with stage IVa laryngeal carcinoma
  • Indicate optimal treatment choices for recurrent laryngeal carcinoma
  • Recall treatment options under investigation in laryngeal cancer, including the use of therapies targeted to epidermal growth factor receptor (EGFR)

Management of a Patient With Advanced Oropharyngeal Squamous Cell Carcinoma Refractory to Platinum-Based Chemotherapy and Radiation

Program Director:
Corey J. Langer, MD

Faculty:

Barbara Burtness, MD headshot
  • Barbara Burtness, MD

CME CREDIT INFORMATION

Release Date: 01/13/06

Expiration Date: 01/12/07


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Test your ability to manage a patient with advanced oropharyngeal cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe appropriate initial management of a patient with advanced oropharyngeal squamous cell carcinoma
  • Discuss the approach to local recurrence with lung involvement in a patient with advanced oropharyngeal squamous cell carcinoma
  • Indicate optimal treatment choices for advanced oropharyngeal squamous cell carcinoma that is refractory to chemotherapy and radiation
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.